We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$397M
AUM Growth
+$8.31M
Cap. Flow
-$5.3M
Cap. Flow %
-1.33%
Top 10 Hldgs %
26.94%
Holding
208
New
42
Increased
62
Reduced
62
Closed
37

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.49M
2
NVO
Novo Nordisk
NVO
+$4.25M
3
PXD
Pioneer Natural Resource Co.
PXD
+$4.17M
4
RING icon
iShares MSCI Global Gold Miners ETF
RING
+$4.15M
5
GILD icon
Gilead Sciences
GILD
+$4.14M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.96M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$6.06M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.8M
4
BKR icon
Baker Hughes
BKR
+$5.25M
5
IXUS icon
iShares Core MSCI Total International Stock ETF
IXUS
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 12.49%
2 Communication Services 10.26%
3 Technology 9.58%
4 Consumer Discretionary 8.95%
5 Industrials 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMPR icon
151
Kemper
KMPR
$1.56B
$266K 0.07%
+3,085
New +$264K
NOA
152
North American Construction
NOA
$414M
$263K 0.07%
24,358
+7,765
+47% +$90.3K
ERIC icon
153
Ericsson
ERIC
$33.4B
$259K 0.07%
+27,240
New +$264K
SAIC icon
154
Saic
SAIC
$5.34B
$259K 0.07%
+2,990
New +$235K
PARA
155
DELISTED
Paramount Global Class B
PARA
$257K 0.06%
5,145
+25
+0.5% +$1.24K
CTLP
156
DELISTED
Cantaloupe
CTLP
$245K 0.06%
32,942
-444
-1% -$2.75K
FBNC icon
157
First Bancorp
FBNC
$2.72B
$240K 0.06%
6,580
+471
+8% +$17.2K
CVLT icon
158
Commault Systems
CVLT
$5.87B
$235K 0.06%
4,735
-73
-2% -$3.88K
FRME icon
159
First Merchants
FRME
$2.72B
$234K 0.06%
6,181
+477
+8% +$17.5K
PEGA icon
160
Pegasystems
PEGA
$5.15B
$234K 0.06%
6,572
-2,044
-24% -$72.8K
EPI icon
161
WisdomTree India Earnings Fund ETF
EPI
$2.04B
$218K 0.05%
8,375
-4,625
-36% -$120K
WKC icon
162
World Kinect Corp
WKC
$1.89B
$217K 0.05%
+6,046
New +$190K
XRAY icon
163
Dentsply Sirona
XRAY
$2.27B
$215K 0.05%
+3,680
New +$198K
DUK icon
164
Duke Energy
DUK
$96.3B
$207K 0.05%
2,346
– –
DK icon
165
Delek US
DK
$4.12B
$201K 0.05%
+4,963
New +$182K
FDD icon
166
First Trust STOXX European Select Dividend Income Fund
FDD
$909M
$179K 0.05%
14,295
-355
-2% -$4.56K
RTW
167
DELISTED
RTW Retailwinds, Inc.
RTW
$177K 0.04%
104,316
-1,227
-1% -$2.67K
UCTT
168
Ultra Clean Holdings
UCTT
$4.1B
$175K 0.04%
+12,550
New +$160K
MIXT
169
DELISTED
MIX TELEMATICS LIMITED
MIXT
$169K 0.04%
11,249
-30
-0.3% -$496
ZIXI
170
DELISTED
Zix Corporation
ZIXI
$166K 0.04%
+18,297
New +$159K
HBIO icon
171
Harvard Bioscience
HBIO
$27.8M
$152K 0.04%
7,594
-227
-3% -$6.65K
AMLP icon
172
Alerian MLP ETF
AMLP
$13.2B
– –
-49,422
Closed -$2.48M
ASHR icon
173
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
– –
-71,836
Closed -$2.06M
BIIB icon
174
Biogen
BIIB
$30.9B
– –
-18,102
Closed -$4.28M
BKR icon
175
Baker Hughes
BKR
$63.8B
– –
-189,255
Closed -$5.25M
5 6
7
8 9

Similar funds

SVCP
Silicon Valley Capital Partners San Jose, California $1.02B AUM 21.85% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Greenwood Capital Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Greenwood Capital Associates held 208 positions worth $397M, up 2.1% from $389M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Greenwood Capital Associates's Q2 2019 filing shows 42 new, 62 increased, 62 reduced and 37 closed positions. Its largest new stake was Merck: 71,722 shares worth $5.74M. The largest sale was Bristol-Myers Squibb, an estimated $6.96M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Communication Services and Technology.

  • Greenwood Capital Associates's largest Q2 2019 buy was Merck: 71,722 shares worth $5.74M.
  • Greenwood Capital Associates added most to Electronic Arts in Q2 2019, an estimated $3.23M increase.
  • Greenwood Capital Associates's biggest Q2 2019 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $6.06M.
  • Greenwood Capital Associates fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $6.96M.
  • Greenwood Capital Associates's ten largest holdings make up 27% of its $397M portfolio in Q2 2019.
  • Greenwood Capital Associates opened 42 new positions and closed 37 in Q2 2019.
  • Greenwood Capital Associates's portfolio value rose 2.1% quarter-over-quarter to $397M.

Based on Greenwood Capital Associates's 13F filing for Q2 2019, filed 13 Aug 2019.